Small Intestine Cancer Clinical Trials
85 clinical trials for Small Intestine Cancer across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Integrated Cancer Repository for Cancer Research — RECRUITING
- Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
- Target-specific immunoPET Imaging of Digestive System Carcinoma — RECRUITING · NA
- Project HERO: Health Empowerment & Recovery Outcomes — COMPLETED · NA
- Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA) — COMPLETED
- Enhanced Assistance During Radiotherapy for Unmet Essential Needs — COMPLETED · NA
- Data Collection of PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy Routine Care Procedures (GPS Study) — WITHDRAWN
- GI Organ Tracking Via Balloon Applicators — WITHDRAWN · NA
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer — COMPLETED · PHASE2
- Nutrition in Gastrointestinal Tumors — COMPLETED
- Programs To Support You During Chemotherapy — COMPLETED · NA
- Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment — COMPLETED · PHASE1
- Treatment for Chronic Pain in Patients With Advanced Cancer — COMPLETED · PHASE3
- Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer — COMPLETED · PHASE1
- Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma — COMPLETED · PHASE1
- PreOPerative Imaging of NeuroEndocrine Tumors — OTHER
- Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment — COMPLETED · PHASE1
- Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma — WITHDRAWN · PHASE2
- Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer — COMPLETED · PHASE2
- Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma — COMPLETED · NA
- Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer — TERMINATED · PHASE2
- Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine — TERMINATED · PHASE2
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer — COMPLETED · PHASE1
- Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder — COMPLETED
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer — COMPLETED · PHASE1
- Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer — COMPLETED
- Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma — COMPLETED
- Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy — COMPLETED · PHASE3
- Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment — COMPLETED · PHASE3
- Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas — COMPLETED · PHASE2
- Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer — TERMINATED
- Enteroscopy for Early Diagnosis of Tumors in Celiac Disease — OTHER · NA
- Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma — COMPLETED · PHASE1
- Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer — COMPLETED · PHASE1
- Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma — COMPLETED · PHASE1
- Flavopiridol in Treating Patients With Refractory Cancer — COMPLETED · PHASE1
- Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer — COMPLETED · PHASE1
- S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction — COMPLETED · PHASE1
- EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer — COMPLETED · PHASE1
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer — COMPLETED · PHASE2
- Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma — OTHER · PHASE2
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma — COMPLETED · PHASE1
- Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas — COMPLETED · PHASE2
- Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors — COMPLETED · PHASE2
- High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma — OTHER · PHASE2
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma — OTHER · PHASE1
- Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia — OTHER · PHASE3
- Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma — COMPLETED · PHASE3
- Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus — COMPLETED · PHASE1
- Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis — WITHDRAWN · PHASE2
Refine this search